The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
Open accessAbstract
Autoimmune hemolytic anemias (AIHAs) are rare and heterogeneous disorders characterized by the destruction of red blood cells through warm or cold antibodies. There is currently no licensed treatment for AIHA. Due to the paucity of clinical trials, recommendations on diagnosis and therapy have often been based on expert opinions and some national guidelines. Here we report the recommendations of the First International Consensus Group, who met with the aim to review currently available data and to provide standardized diagnostic criteria and therapeutic approaches as well as an overview of novel therapies. Exact diagnostic workup is important because symptoms, course of disease, and therapeutic management relate to the type of antibody involved. Monospecific direct antiglobulin test is considered mandatory in the diagnostic workup, and any causes of secondary AIHA have to be diagnosed. Corticosteroids remain first-line therapy for warm-AIHA, while the addition of rituximab should be considered early in severe cases and if no prompt response to steroids is achieved. Rituximab with or without bendamustine should be used in the first line for patients with cold agglutinin disease requiring therapy. We identified a need to establish an international AIHA network. Future recommendations should be based on prospective clinical trials whenever possible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rodeghiero, F., Stasi, R., Gernsheimer, T., Michel, M., Provan, D., Arnold, D. M., Bussel, J. B., Cines, D. B., Chong, B. H., Cooper, N., et al. (2009) · Blood · doi:10.1182/blood-2008-07-162503 · Cited by 2,690
Self-citationFcRn: the neonatal Fc receptor comes of age
Roopenian, D. C., & Akilesh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2155 · Cited by 2,346
Hematology: Basic Principles and Practice
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-238_2 · Cited by 1,857
MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia
Treon, S. P., Xu, L., Yang, G., Zhou, Y., Liu, X., Cao, Y., Sheehy, P., Manning, R. J., Patterson, C. J., Tripsas, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200710 · Cited by 1,294
Mechanisms of Cell Protection by Heme Oxygenase-1
Gozzelino, R., Jeney, V., & Soares, M. P. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105600 · Cited by 1,241 · cited 1×
“LDH is particularly elevated in intravascular hemolysis, and unconjugated bilirubin in extravascular RBC destruction, but they are not specific, being present in many other conditions [51].”
BackgroundThomas, C. F., & Limper, A. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032588 · Cited by 1,037
García Rodríguez, L., & Jick, H. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91843-0 · Cited by 975
Ibrutinib in Previously Treated Waldenström’s Macroglobulinemia
Treon, S. P., Tripsas, C. K., Meid, K., Warren, D., Varma, G., Green, R., Argyropoulos, K. V., Yang, G., Cao, Y., Xu, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501548 · Cited by 942
UK clinical guideline for the prevention and treatment of osteoporosis
The National Osteoporosis Guideline Group (NOGG), Compston, J., Cooper, A., Cooper, C., Gittoes, N., Gregson, C., Harvey, N., Hope, S., Kanis, J. A., McCloskey, E. V., et al. (2017) · Archives of Osteoporosis · doi:10.1007/s11657-017-0324-5 · Cited by 826
Stilgenbauer, S., Eichhorst, B., Schetelig, J., Coutre, S., Seymour, J. F., Munir, T., Puvvada, S. D., Wendtner, C.-M., Roberts, A. W., Jurczak, W., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30019-5 · Cited by 805
Gehrs, B. C., & Friedberg, R. C. (2002) · American Journal of Hematology · doi:10.1002/ajh.10062 · Cited by 647
Corticosteroid Use and Peptic Ulcer Disease: Role of Nonsteroidal Anti-inflammatory Drugs
Piper, J. M., Ray, W. A., Daugherty, J. R., & Griffin, M. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-735 · Cited by 608
Buckley, L., Guyatt, G., Fink, H. A., Cannon, M., Grossman, J., Hansen, K. E., Humphrey, M. B., Lane, N. E., Magrey, M., Miller, M., et al. (2017) · Arthritis Care & Research · doi:10.1002/acr.23279 · Cited by 579
Szczepiorkowski, Z. M., Bandarenko, N., Kim, H. C., Linenberger, M. L., Marques, M. B., Sarode, R., Schwartz, J., Shaz, B. H., Weinstein, R., Wirk, A., et al. (2007) · Journal of Clinical Apheresis · doi:10.1002/jca.20129 · Cited by 546
Szczepiorkowski, Z. M., Winters, J. L., Bandarenko, N., Kim, H. C., Linenberger, M. L., Marques, M. B., Sarode, R., Schwartz, J., Weinstein, R., & Shaz, B. H. (2010) · Journal of Clinical Apheresis · doi:10.1002/jca.20240 · Cited by 508
Barcellini, W., Fattizzo, B., Zaninoni, A., Radice, T., Nichele, I., Di Bona, E., Lunghi, M., Tassinari, C., Alfinito, F., Ferrari, A., et al. (2014) · Blood · doi:10.1182/blood-2014-06-583021 · Cited by 382
Self-citationBussel, J., Arnold, D. M., Grossbard, E., Mayer, J., Treliński, J., Homenda, W., Hellmann, A., Windyga, J., Sivcheva, L., Khalafallah, A. A., et al. (2018) · American Journal of Hematology · doi:10.1002/ajh.25125 · Cited by 368
Davies, J. M., Lewis, M. P. N., Wimperis, J., Rafi, I., Ladhani, S., & Bolton‐Maggs, P. H. B. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08843.x · Cited by 341
Joint IOF-ECTS GIO Guidelines Working Group, Lekamwasam, S., Adachi, J. D., Agnusdei, D., Bilezikian, J., Boonen, S., Borgström, F., Cooper, C., Diez Perez, A., Eastell, R., et al. (2012) · Osteoporosis International · doi:10.1007/s00198-012-1958-1 · Cited by 335
Swiecicki, P. L., Hegerova, L. T., & Gertz, M. A. (2013) · Blood · doi:10.1182/blood-2013-02-474437 · Cited by 324
Self-citationThe diagnosis and management of primary autoimmune haemolytic anaemia
Hill, Q. A., Stamps, R., Massey, E., Grainger, J. D., Provan, D., Hill, A., & the British Society for Haematology (2017) · British Journal of Haematology · doi:10.1111/bjh.14478 · Cited by 275
Self-citationPodolanczuk, A., Lazarus, A. H., Crow, A. R., Grossbard, E., & Bussel, J. B. (2009) · Blood · doi:10.1182/blood-2008-07-166439 · Cited by 263
Ognibene, F. P., Shelhamer, J. H., Hoffman, G. S., Kerr, G. S., Reda, D., Fauci, A. S., & Leavitt, R. Y. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.3.7881673 · Cited by 210
Risitano, A. M., Ricklin, D., Huang, Y., Reis, E. S., Chen, H., Ricci, P., Lin, Z., Pascariello, C., Raia, M., Sica, M., et al. (2014) · Blood · doi:10.1182/blood-2013-11-536573 · Cited by 194
Flores, G., Cunningham‐Rundles, C., Newland, A. C., & Bussel, J. B. (1993) · American Journal of Hematology · doi:10.1002/ajh.2830440404 · Cited by 186
Rituximab in chronic cold agglutinin disease: a prospective study of 20 patients
Schöllkopf, C., Kjeldsen, L., Bjerrum, O. W., Mourits-Andersen, H. T., Nielsen, J. L., Christensen, B. E., Jensen, B. A., Pedersen, B. B., Taaning, E. B., Klausen, T. W., et al. (2006) · Leukemia & Lymphoma · doi:10.1080/10428190500286481 · Cited by 175
Haematological manifestations of systemic lupus erythematosus
Keeling, D. M., & Isenberg, D. A. (1993) · Blood Reviews · doi:10.1016/0268-960x(93)90006-p · Cited by 172
New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia
Barcellini, W. (2015) · Transfusion Medicine and Hemotherapy · doi:10.1159/000439002 · Cited by 171
Self-citationNext-generation Fc receptor–targeting biologics for autoimmune diseases
Zuercher, A. W., Spirig, R., Morelli, A. B., Rowe, T., & Käsermann, F. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102366 · Cited by 162
Risk for Hospital Contact With Infection in Patients With Splenectomy
Thomsen, R. W., Schoonen, W. M., Farkas, D. K., Riis, A., Jacobsen, J., Fryzek, J. P., & Sørensen, H. T. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-8-200910200-00008 · Cited by 161
Michel, M., Terriou, L., Roudot‐Thoraval, F., Hamidou, M. A., Ebbo, M., Guenno, G. L., Galicier, L., Audia, S., Royer, B., Morin, A. S., et al. (2016) · American Journal of Hematology · doi:10.1002/ajh.24570 · Cited by 157
Self-citationRoumier, M., Loustau, V., Guillaud, C., Languille, L., Mahévas, M., Khellaf, M., Limal, N., Pirenne, F., Godeau, B., & Michel, M. (2014) · American Journal of Hematology · doi:10.1002/ajh.23767 · Cited by 156
Self-citationLong-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia
Treon, S. P., Branagan, A. R., Ioakimidis, L., Soumerai, J. D., Patterson, C. J., Turnbull, B. A., Wasi, P., Emmanouilides, C. E., Frankel, S. R., Lister, A. T., et al. (2008) · Blood · doi:10.1182/blood-2008-09-177329 · Cited by 153
The Changing Spectrum of Drug-Induced Immune Hemolytic Anemia
Arndt, P. A., & Garratty, G. (2005) · Seminars in Hematology · doi:10.1053/j.seminhematol.2005.04.004 · Cited by 146
Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome. More patients, same risk
Sepkowitz, K. A. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.11.1125 · Cited by 138
Diagnosis and classification of autoimmune hemolytic anemia
Bass, G. F., Tuscano, E., & Tuscano, J. M. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.11.010 · Cited by 134
Huang, L., Morris, A. M., LIMPER, A. H., Beck, J. M., & Participants, O. B. O. T. A. P. W. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200602-015ms · Cited by 133
The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man.
Jaffe, C. J., Atkinson, J. P., & Frank, M. M. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108547 · Cited by 128
Amelioration of Experimental Autoimmune Myasthenia Gravis in Rats by Neonatal FcR Blockade
Liu, L., Garcia, A. M., Santoro, H., Zhang, Y., McDonnell, K. A., Dumont, J., & Bitonti, A. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5390 · Cited by 126
Pneumocystis carinii Pneumonia Without Acquired Immunodeficiency Syndrome
Sepkowitz, K. A. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430110015002 · Cited by 126
The Predictive Value of Serum Haptoglobin in Hemolytic Disease
Marchand, A. (1980) · JAMA · doi:10.1001/jama.1980.03300450023014 · Cited by 123
Stuck, A. K., Spirk, D., Schaudt, J., & Kucher, N. (2017) · Thrombosis and Haemostasis · doi:10.1160/th16-08-0631 · Cited by 113
Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease
Röth, A., Hüttmann, A., Rother, R. P., Dührsen, U., & Philipp, T. (2009) · Blood · doi:10.1182/blood-2009-01-196329 · Cited by 112
Self-citationYusuf, H. R., Hooper, W. C., Grosse, S. D., Parker, C. S., Boulet, S. L., & Ortel, T. L. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.10.012 · Cited by 112
Thromboembolic complications after splenectomy for hematologic diseases
Mohren, M., Markmann, I., Dworschak, U., Franke, A., Maas, C., Mewes, S., Weiß, G., & Jentsch‐Ullrich, K. (2004) · American Journal of Hematology · doi:10.1002/ajh.20018 · Cited by 111
Potter, K. N., Hobby, P., Klijn, S., Stevenson, F. K., & Sutton, B. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3777 · Cited by 110
Rogers, K. A., Ruppert, A. S., Bingman, A. K., Andritsos, L. A., Awan, F. T., Blum, K. A., Flynn, J. M., Jaglowski, S. M., Lozanski, G., Maddocks, K. J., et al. (2015) · Leukemia · doi:10.1038/leu.2015.273 · Cited by 103
Danazol Therapy for Autoimmune Hemolytic Anemia
Ahn, Y. S., Harrington, W. J., Mylvaganam, R., Ayub, J., & PALL, L. M. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-3-298 · Cited by 102
Nielsen, G. L., Sørensen, H. T., Mellemkjøer, L., Blot, W. J., McLaughlin, J. K., Tage‐Jensen, U., & Olsen, J. H. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00941-x · Cited by 97
Serris, A., Amoura, Z., Canouï‐Poitrine, F., Terrier, B., HACHULLA, E., Costedoat-Chalumeau, N., Papo, T., Lambotte, O., Saadoun, D., Hié, M., et al. (2017) · American Journal of Hematology · doi:10.1002/ajh.24999 · Cited by 93
Self-citationDrug therapy of autoimmune hemolytic anemia.
Murphy, S., & LoBuglio, A. F. (1976) · PubMed · Cited by 83
Immunoglobulin treatment in primary antibody deficiency
Maarschalk-Ellerbroek, L. J., Hoepelman, I. M., & Ellerbroek, P. M. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.11.027 · Cited by 83
Portal Vein Thrombosis following Splenectomy: Identification of Risk Factors
Fujita, F., Lyass, S., Otsuka, K., Giordano, L., Rosenbaum, D., Khalili, T. M., & Phillips, E. H. (2003) · The American Surgeon · doi:10.1177/000313480306901107 · Cited by 81
Cao, Y., Yang, G., Hunter, Z. R., Liu, X., Xu, L., Chen, J., Tsakmaklis, N., Hatjiharissi, E., Kanan, S., Davids, M. S., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13278 · Cited by 81
Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review
Salama, A. (2015) · Transfusion Medicine and Hemotherapy · doi:10.1159/000438731 · Cited by 80
Kruizinga, M. D., van Tol, M. J. D., Bekker, V., Netelenbos, T., Smiers, F. J. W., Bresters, D., Jansen-Hoogendijk, A. M., Dam, M. M. V. O.-T., Kollen, W. J. W., Zwaginga, J. J., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.12.782 · Cited by 79
Application of the Predictive Value Model in the Analysis of Test Effectiveness
Galen, R. S. (1982) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)31007-2 · Cited by 77
MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia
Abeykoon, J. P., Paludo, J., King, R. L., Ansell, S. M., Gertz, M. A., LaPlant, B. R., Halvorson, A. E., Gonsalves, W. I., Dingli, D., Fang, H., et al. (2017) · American Journal of Hematology · doi:10.1002/ajh.24955 · Cited by 70
Self-citationVenous thromboembolism related to warm autoimmune hemolytic anemia: A case–control study
Lecouffe-Desprets, M., Néel, A., Graveleau, J., Leux, C., Perrin, F., Visomblain, B., Artifoni, M., MASSEAU, A., Connault, J., Pottier, P., et al. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.07.001 · Cited by 67
Barcellini, W., Clerici, G., Montesano, R., Taioli, E., Morelati, F., Rebulla, P., & Zanella, A. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02380.x · Cited by 67
Self-citationKarlsson, C., Hansson, L., Celsing, F., & Lundin, J. (2007) · Leukemia · doi:10.1038/sj.leu.2404512 · Cited by 61
Montillo, M., O'Brien, S. M., Tedeschi, A., Byrd, J. C., Dearden, C. E., Gill, D. S., Brown, J. R., Barrientos, J. C., Mulligan, S. P., Furman, R. R., et al. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.5 · Cited by 61
Self-citationAmiche, M. A., Lévesque, L. E., Gomes, T., Adachi, J. D., & Cadarette, S. M. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3318 · Cited by 61
Paulus, A., Akhtar, S., Yousaf, H., Manna, A., Paulus, S. M., Bashir, Y., Caulfield, T. R., Blake, M. K., Chitta, K. S., Wang, X., et al. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.40 · Cited by 57
Autoimmune hemolytic anemia and ovarian dermoid cysts: Case report and review of the literature
Payne, D. G., Muss, H. B., Homesley, H. D., Jobson, V. W., & Baird, F. G. (1981) · Cancer · Cited by 55
Autoimmune hemolytic anemia and venous thromboembolism: A systematic review and meta-analysis
Ungprasert, P., Tanratana, P., & Srivali, N. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.09.004 · Cited by 54
von Baeyer, H. (2003) · Therapeutic Apheresis and Dialysis · doi:10.1046/j.1526-0968.2003.00004.x · Cited by 54
Hampel, P. J., Larson, M. C., Kabat, B., Call, T. G., Ding, W., Kenderian, S. S., Bowen, D. A., Boysen, J. C., Schwager, S. M., Leis, J. F., et al. (2018) · British Journal of Haematology · doi:10.1111/bjh.15545 · Cited by 53
Manda, S., Dunbar, N. M., Marx‐Wood, C. R., & Danilov, A. V. (2015) · British Journal of Haematology · doi:10.1111/bjh.13328 · Cited by 47
Thomas, T., Horlait, S., Ringe, J. D., Abelson, A. G., Gold, D. T., Atlan, P., & Lange, J. L. (2012) · Osteoporosis International · doi:10.1007/s00198-012-2060-4 · Cited by 45
Combined integrated protocol/basket trial design for a first-in-human trial
Derhaschnig, U., Gilbert, J., Jaeger, U., Böhmig, G. A., Stingl, G., & Jilma, B. (2016) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-016-0494-z · Cited by 44
Self-citationRituximab as successful therapy in a patient with refractory paroxysmal cold hemoglobinuria
Koppel, A. B., Lim, S. W., Osby, M., Garratty, G., & Goldfinger, D. (2007) · Transfusion · doi:10.1111/j.1537-2995.2007.01414.x · Cited by 42
Congenital Anhaptoglobinemia Versus Acquired Hypohaptoglobinemia
Delanghe, J., Langlois, M. R., & Buyzere, M. D. (1998) · Blood · doi:10.1182/blood.v91.9.3524 · Cited by 40
Complement inhibitors to treat IgM-mediated autoimmune hemolysis
Wouters, D., & Zeerleder, S. S. (2015) · Haematologica · doi:10.3324/haematol.2015.128538 · Cited by 39
Self-citationGuideline for the treatment of chronic lymphocytic leukaemia
Schuh, A., Parry‐Jones, N., Appleby, N., Bloor, A. J. C., Dearden, C. E., Fegan, C., Follows, G., Fox, C. P., Iyengar, S., Kennedy, B., et al. (2018) · British Journal of Haematology · doi:10.1111/bjh.15460 · Cited by 36
Overman, R. A., Gourlay, M. L., Deal, C. L., Farley, J. F., Brookhart, M. A., & Layton, J. B. (2015) · Osteoporosis International · doi:10.1007/s00198-014-3022-9 · Cited by 35
Evidence based therapeutic apheresis in autoimmune and other hemolytic anemias
McLeod, B. C. (2007) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3282c8ca66 · Cited by 29
Nakasone, H., Kako, S., Endô, H., Ito, A., Sato, M., Terasako, K., Okuda, S., Tanaka, Y., Yamazaki, R., Oshima, K., et al. (2009) · Hematology · doi:10.1179/102453309x12473408860262 · Cited by 23
A Novel Approach for Treatment of Cold Agglutinin Syndrome-Related Severe Hemolysis
Tesfaye, A. A., & Broome, C. M. (2016) · Journal of Hematology · doi:10.14740/jh242w · Cited by 23
Self-citationWong, R. S. M., Pullon, H. W. H., Deschatelets, P., Francois, C. G., Hamdani, M., Issaragrisil, S., Johnson, P., Niparuck, P., Numbenjapon, T., Sathar, J., et al. (2018) · Blood · doi:10.1182/blood-2018-99-110827 · Cited by 23
Cavazzini, F., Lista, E., Quaglia, F. M., Formigaro, L., Cavallari, M., Martinelli, S., Rigolin, G. M., Foà, R., & Cuneo, A. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2016.1154955 · Cited by 21
Schützinger, C., Gaiger, A., Thalhammer, R., Vesely, M., Fritsche‐Polanz, R., Schwarzinger, I., Öhler, L., Simonitsch-Klupp, I., Reinhard, F., & Jaeger, U. (2005) · Leukemia · doi:10.1038/sj.leu.2403956 · Cited by 20
Kjellander, C., Björkholm, M., Källman, O., Giske, C. G., Weibull, C. E., Löve, Þ. J., Landgren, O., & Kristinsson, S. Y. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2643-9 · Cited by 15
Cited by
Anand, U., Dey, A., Chandel, A. K. S., Sanyal, R., Mishra, A., Pandey, D. K., De Falco, V., Upadhyay, A., Kandimalla, R., Chaudhary, A., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.02.007 · Cited by 1,834
Connelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
Metadata
- Authors
- Jäger, U., Barcellini, W., Broome, C. M., Gertz, M. A., Hill, A., Hill, Q. A., Jilma, B., Kuter, D. J., Michel, M., Montillo, M., Röth, A., Zeerleder, S. S., & Berentsen, S.
- Venue
- Blood Reviews
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 41
- Pages
- 100648
- ISSN
- 0268-960X (ISSN-L)
- OpenAlex
- W2994304950
- Cited by
- 565
- References
- 83
- FWCI
- 30.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.